Submitted by Anonymous (not verified) on 26 November 2025 - 14:00
Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Date of authorisation: 15/01/2018, Revision: 16, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Mvasi, bevacizumab, Date of authorisation: 15/01/2018, Revision: 16, Status: Authorised